Details

Title
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
Author
Zhang, Liyang 1 ; Zuris, John A 2 ; Viswanathan Ramya 2 ; Edelstein, Jasmine N 2 ; Turk, Rolf 1   VIAFID ORCID Logo  ; Thommandru Bernice 1 ; Tomas, Rube H 3 ; Glenn, Steve E 1 ; Collingwood, Michael A 1 ; Bode, Nicole M 1   VIAFID ORCID Logo  ; Beaudoin, Sarah F 1   VIAFID ORCID Logo  ; Lele Swarali 2 ; Scott, Sean N 2 ; Wasko, Kevin M 2 ; Sexton, Steven 2 ; Borges, Christopher M 2 ; Schubert, Mollie S 1 ; Kurgan, Gavin L 1   VIAFID ORCID Logo  ; McNeill, Matthew S 1   VIAFID ORCID Logo  ; Fernandez, Cecilia A 2 ; Myer, Vic E 2 ; Morgan, Richard A 2 ; Behlke, Mark A 1   VIAFID ORCID Logo  ; Vakulskas, Christopher A 1   VIAFID ORCID Logo 

 Integrated DNA Technologies, Inc, Coralville, USA (GRID:grid.420360.3) (ISNI:0000 0004 0507 0833) 
 Editas Medicine Inc, Cambridge, USA (GRID:grid.509180.5) (ISNI:0000 0004 5907 5533) 
 University of California - Merced, Merced, USA (GRID:grid.266096.d) (ISNI:0000 0001 0049 1282) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2553124567
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.